Variant report
Variant | nsv945968 |
---|---|
Chromosome Location | chr1:58071136-58073409 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | JUND | chr1:58073283-58073482 | HepG2 | liver: | n/a | chr1:58073399-58073408 |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-C8B-3 | chr1:58071519-58071878 | NONHSAT003477 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPS20P5 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs111658598 | chr1:58071227-58071228 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs539497967 | chr1:58071231-58071232 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556119732 | chr1:58071391-58071392 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs4912266 | chr1:58071430-58071431 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs542136631 | chr1:58071457-58071458 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs569730641 | chr1:58071468-58071469 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536701428 | chr1:58071469-58071470 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201693495 | chr1:58071478-58071479 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs200419530 | chr1:58071479-58071480 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576036371 | chr1:58071491-58071492 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555735377 | chr1:58071513-58071514 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs373245959 | chr1:58071534-58071535 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs371734789 | chr1:58071549-58071550 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs572608579 | chr1:58071554-58071555 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs375954620 | chr1:58071617-58071618 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs61769602 | chr1:58071631-58071632 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs541254405 | chr1:58071634-58071635 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs564252793 | chr1:58071644-58071645 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs191473187 | chr1:58071680-58071681 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs112008823 | chr1:58071684-58071685 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs543478403 | chr1:58071690-58071691 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs367887388 | chr1:58071718-58071719 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs370428922 | chr1:58071719-58071720 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs374428589 | chr1:58071720-58071721 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs398073967 | chr1:58071721-58071722 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs397957214 | chr1:58071722-58071723 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs563288613 | chr1:58071787-58071788 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs528867976 | chr1:58071819-58071820 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs367855105 | chr1:58071832-58071833 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs144281441 | chr1:58071842-58071843 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs565797895 | chr1:58071846-58071847 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs528331098 | chr1:58071860-58071861 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs10736394 | chr1:58071960-58071961 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs570954776 | chr1:58071961-58071962 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184685679 | chr1:58071978-58071979 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs112558844 | chr1:58071989-58071990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs369982501 | chr1:58072048-58072049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs369222646 | chr1:58072049-58072050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs58167700 | chr1:58072063-58072064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs71051241 | chr1:58072064-58072065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs368292962 | chr1:58072065-58072066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs372268093 | chr1:58072067-58072068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs72388336 | chr1:58072175-58072176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs61308488 | chr1:58072185-58072186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs371830796 | chr1:58072191-58072192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376654701 | chr1:58072200-58072201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs367718985 | chr1:58072201-58072202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs11588587 | chr1:58072235-58072236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs376381766 | chr1:58072236-58072237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs374907138 | chr1:58072252-58072253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Papillary thyroid carcinoma | 21436994 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Meckel-Gruber syndrome | 21572526 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 19490664 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 22522925 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:58065800-58071600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr1:58066000-58077200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr1:58066000-58089000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr1:58066400-58089400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr1:58066600-58074400 | Weak transcription | Fetal Heart | heart |
6 | chr1:58067600-58071200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
7 | chr1:58069400-58072000 | Enhancers | H9 Cell Line | embryonic stem cell |
8 | chr1:58069800-58071600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr1:58069800-58085400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr1:58070000-58071400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
11 | chr1:58070200-58071200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
12 | chr1:58070600-58072000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr1:58070800-58072000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr1:58071000-58071200 | Enhancers | H1 Cell Line | embryonic stem cell |
15 | chr1:58071000-58071800 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
16 | chr1:58071000-58071800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr1:58071200-58071400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
18 | chr1:58071200-58071600 | Weak transcription | H1 Cell Line | embryonic stem cell |
19 | chr1:58071200-58071600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
20 | chr1:58071200-58072000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
21 | chr1:58071400-58071800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
22 | chr1:58071600-58072000 | Enhancers | H1 Cell Line | embryonic stem cell |
23 | chr1:58071600-58072000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
24 | chr1:58071800-58073600 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
25 | chr1:58072000-58072400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |